Azee Rediuse 200 mg Cipla

What Is Azee Rediuse 200 mg? Azee Rediuse 200 mg is a macrolide antibiotic formulation manufactured by Cipla, with azithromycin as its active pharmaceutical ingredient. Azithromycin belongs to the azalide subclass of macrolides — a structurally distinct group characterised by a 15-membered lactone ring. In laboratory settings, this compound demonstrates broad-spectrum antimicrobial activity against a range of gram-positive and gram-negative bacterial strains, making it a frequently referenced agent in microbiological research. Researchers sourcing quality-assured compounds from uksteroidshops.co.uk benefit from pharmaceutical-grade manufacturing backed by Cipla’s established production standards. Research Applications and Investigative Uses Scientific interest in azithromycin centres on several key areas. Investigators examine its mechanism of action — inhibition of bacterial protein synthesis via binding to the 50S ribosomal subunit — to better understand how macrolide-class agents interfere with bacterial replication cycles. Researchers also evaluate azithromycin’s pharmacokinetic properties, including its notably long tissue half-life and high intracellular accumulation, which distinguish it from earlier macrolide compounds. Studies explore its utility in resistance-pattern profiling, particularly regarding efflux-pump-mediated and ribosomal-methylation resistance mechanisms observed in gram-positive organisms. Those researching pharmaceutical formulations can also compare azithromycin’s profile alongside compounds available in our Azithromycin category, where additional formulations and concentrations are listed for reference. Beyond antimicrobial mechanisms, azithromycin has attracted attention in immunomodulatory research owing to its observed effects on cytokine signalling in cell culture and animal models. Azee Rediuse 200 mg — Technical Specifications Parameter Detail Active Ingredient Azithromycin CAS Number 83905-01-5 Molecular Formula C₃₈H₇₂N₂O₁₂ Molecular Weight 748.98 g/mol Strength 200 mg per unit Antibiotic Class Macrolide / Azalide Manufacturer Cipla SKU EU14158 Storage Room temperature, dry, away from direct light Research Grade Pharmaceutical-grade API Broader Research Context and Compliance Researchers studying antimicrobial agents often place azithromycin within a wider pharmacological landscape that includes hormone-modulating compounds. For context, our catalogue also features extensively studied agents in areas such as oral steroids and injectable steroids, allowing investigators to source multiple compound classes from one verified supplier. Azee Rediuse 200 mg is supplied strictly for in-vitro research, laboratory analysis, and academic investigation purposes. This product is not intended for human consumption, veterinary use, or therapeutic application without appropriate professional authorisation. Purchasers must be aged 18 or over. All use must comply with applicable UK legislation and institutional research governance frameworks. Nothing on this page constitutes medical advice.